PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, University of Houston, Houston, TX (JDT, TJV, SSB); College of Pharmacy, Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, Houston, TX (CGD); Division of Outcomes Research and Quality, Department of Surgery, Pennsylvania State College of Medicine, Hershey, PA (CS).\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/ADM.0000000000000756
?:doi
?:hasPublicationType
?:journal
  • Journal of addiction medicine
is ?:pmid of
?:pmid
?:pmid
  • 33031213
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.063
?:rankingScore_hIndex
  • 32
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33031213>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33031213>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all